Does INSULIN GLARGINE Cause Mobility decreased? 258 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 258 reports of Mobility decreased have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 0.3% of all adverse event reports for INSULIN GLARGINE.
258
Reports of Mobility decreased with INSULIN GLARGINE
0.3%
of all INSULIN GLARGINE reports
3
Deaths
63
Hospitalizations
How Dangerous Is Mobility decreased From INSULIN GLARGINE?
Of the 258 reports, 3 (1.2%) resulted in death, 63 (24.4%) required hospitalization, and 4 (1.6%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE. However, 258 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN GLARGINE Cause?
Blood glucose increased (19,234)
Inappropriate schedule of product administration (8,982)
Product storage error (7,743)
Off label use (6,842)
Visual impairment (5,793)
Blood glucose decreased (4,552)
Drug ineffective (4,351)
Hypoglycaemia (4,212)
Injection site pain (3,574)
Device issue (3,175)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which INSULIN GLARGINE Alternatives Have Lower Mobility decreased Risk?
INSULIN GLARGINE vs INSULIN GLARGINE-YFGN
INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE vs INSULIN GLULISINE
INSULIN GLARGINE vs INSULIN HUMAN
INSULIN GLARGINE vs INSULIN LISPRO